Business
Why the Orthocell (ASX:OCC) share price is edging higher today
The Orthocell Ltd (ASX: OCC) share price is edging higher today. This comes after the company announced it has completed an important step to obtaining its commercial licence in Australia for its CelGro medical device.
During market open, the Orthocell share price reached as high as 43.5 cents. However, at the time of writing, the company’s shares have slightly retreated to 42.5 cents, up 1.2%.
Quick take on Orthocell
Orthocell focuses on the development and commercialisation of novel collagen medical devices and cellular therapies.
Its lead product, CelGro, facilitates tissue repair and healing in a variety of orthopaedic, reconstructive and surgical applications. This includes treating defects in areas of the body such as…
-
Noosa News19 hours agoGirl, 15, rushed to hospital in life-threatening condition after being hit by car in Townsville
-
Noosa News18 hours agoNew Sci-Fi Drama ‘Pluribus’ Reunites ‘Breaking Bad’ Creator Vince Gilligan with ‘Better Call Saul’ Star Rhea Seehorn — and It Has a Teaser Trailer
-
Noosa News23 hours agoNeed for Feed Australia truck convoy hits Nullarbor for South Australia drought relief
-
General22 hours agoAdvance used unblurred footage of minors taken from education organisations without consent in new ad